Minireview: Intraislet regulation of insulin secretion in humans

Molecular Endocrinology

Volumn 27, Issue 12, 2013, Pages 1984-1995

  Rutter, Guy A ^a   Hodson, David J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

CELL COMMUNICATION; ENVIRONMENTAL FACTOR; GLUCOSE INTOLERANCE; HEREDITY; HORMONAL REGULATION; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; RODENT; SPECIES DIFFERENCE; SYNCYTIUM;

ELECTROPHYSIOLOGICAL PHENOMENA; GENOME-WIDE ASSOCIATION STUDY; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS;

EID: 84888371075     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1278     Document Type: Review

References (126)

1. International Diabetes Federation. IDF Diabetes Atlas, 5th ed. Brussels, Belgium: International Diabetes Federation; 2011.
2. Rutter GA. Nutrient-secretion coupling in the pancreatic islet β-cell: recent advances. Mol Aspects Med. 2001;22:247-284.
3. Meglasson MD, Matschinsky FM. Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab Rev. 1986;2:163-214.
4. Tarasov AI, Semplici F, Ravier MA, Bellomo EA, Pullen TJ, Gilon P, Sekler I, Rizzuto R, Rutter GA. The mitochondrial Ca2+ uniporter MCU is essential for glucose-induced ATP increases in pancreatic β-cells. PloS One. 2012;7:e39722.
5. Pullen TJ, Rutter GA. When less is more: the forbidden fruits of gene repression in the adult β-cell. Diabetes Obes Metab. 2013; 15:503-512.
6. Sekine N, Cirulli V, Regazzi R, et al. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic β-cells. Potential role in nutrient sensing. J Biol Chem. 1994;269:4895-4902.
7. Ashcroft FM, Harrison DE, Ashcroft SJ. Glucose induces closure of single potassium channels in isolated rat pancreatic β-cells. Nature. 1984;312:446-448.
8. Cook DL, Hales CN. Intracellular ATP directly blocks K+ channels in pancreatic B-cells. Nature. 1984;311:271-273.
9. Rutter GA. Visualising insulin secretion. The Minkowski Lecture 2004. Diabetologia. 2004;47:1861-1872.
10. Braun M, Ramracheya R, Bengtsson M, Zhang Q, Karanauskaite J, Partridge C, Johnson PR, Rorsman P. Voltage-gated ion channels in human pancreatic β-cells: electrophysiological characterization and role in insulin secretion. Diabetes. 2008;57:1618-1628.
11. st ed. The Netherlands: Springer; 2010
12. Rorsman P, Braun M. Regulation of insulin secretion in human pancreatic islets. Annu Rev Physiol. 2013;75:155-179.
13. Straub SG, Cosgrove KE, Ammälä C, et al. Hyperinsulinism of infancy: the regulated release of insulin by KATP channel-independent pathways. Diabetes. 2001;50:329-339.
14. Henquin JC. Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia. 2009;52:739-751.
15. Komatsu M, Schermerhorn T, Aizawa T, Sharp GW. Glucose stimulation of insulin release in the absence of extracellular Ca2+ and in the absence of any increase in intracellular Ca2+ in rat pancreatic islets. Proc Natl Acad Sci USA. 1995;92:10728-10732.
16. Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes. 2000;49:1751-1760.
17. Henquin JC. The dual control of insulin secretion by glucose involves triggering and amplifying pathways in β-cells. Diabetes Res Clin Pract. 2011;93(Suppl. 1):S27-S31.
18. Payandeh J, Scheuer T, Zheng N, Catterall WA. The crystal structure of a voltage-gated sodium channel. Nature. 2011;475:353-358.
19. Barnett DW, Pressel DM, Misler S. Voltage-dependent Na+ and Ca2+currents in human pancreatic islet β-cells: evidence for roles in the generation of action potentials and insulin secretion. Pflugers Arch. 1995;431:272-282.
20. Jacobson DA, Mendez F, Thompson M, Torres J, Cochet O, Philipson LH. Calcium-activated and voltage-gated potassium channels of the pancreatic islet impart distinct and complementary roles during secretagogue induced electrical responses. J Physiol. 2010;588:3525-3537.
21. Sanchez-Cardenas C, Fontanaud P, He Z, et al. Pituitary growth hormone network responses are sexually dimorphic and regulated by gonadal steroids in adulthood. Proc Natl Acad Sci USA. 2010; 107:21878-21883.
22. Hodson DJ, Molino F, Fontanaud P, Bonnefont X, Mollard P. Investigating and modelling pituitary endocrine network function. J Neuroendocrinol. 2010;22:1217-1225.
23. Hodson DJ, Schaeffer M, Romano N, et al. Existence of longlasting experience-dependent plasticity in endocrine cell networks. Nat Commun. 2012;3:605.
24. Mollard P, Hodson DJ, Lafont C, Rizzoti K, Drouin J. A tridimensional view of pituitary development and function. Trends Endocrinol Metab. 2012;23:261-269.
25. Stozer A, Gosak M, Dolensek J, et al. Functional connectivity in islets of Langerhans from mouse pancreas tissue slices. PLoS Comp Biol. 2013;9:e1002923.
26. Santos RM, Rosario LM, Nadal A, Garcia-Sancho J, Soria B, Valdeolmillos M. Widespread synchronous [Ca2+]i oscillations due to bursting electrical activity in single pancreatic islets. Pflugers Arch. 1991;418:417-422.
27. Gilon P, Henquin JC. Influence of membrane potential changes on cytoplasmic Ca2+ concentration in an electrically excitable cell, the insulin-secreting pancreatic B-cell. J Biol Chem. 1992;267: 20713-20720.
28. Rocheleau JV, Remedi MS, Granada B, et al. Critical role of gap junction coupled KATP channel activity for regulated insulin secretion. PLoS Biol. 2006;4:e26.
29. Benninger RK, Zhang M, Head WS, Satin LS, Piston DW. Gap junction coupling and calcium waves in the pancreatic islet. Biophys J. 2008;95:5048-5061.
30. Head WS, Orseth ML, Nunemaker CS, Satin LS, Piston DW, Benninger RK. Connexin-36 gap junctions regulate in vivo first-and second-phase insulin secretion dynamics and glucose tolerance in the conscious mouse. Diabetes. 2012;61:1700-1707.
31. Stozer A, Dolensek J, Rupnik MS. Glucose-stimulated calcium dynamics in islets of Langerhans in acute mouse pancreas tissue slices. PloS One. 2013;8:e54638.
32. Salomon D, Meda P. Heterogeneity and contact-dependent regulation of hormone secretion by individual B cells. Exp Cell Res. 1986;162:507-520.
33. Bosco D, Meda P. Actively synthesizing β-cells secrete preferentially after glucose stimulation. Endocrinology. 1991;129:3157-3166.
34. Kinard TA, de Vries G, Sherman A, Satin LS. Modulation of the bursting properties of single mouse pancreatic β-cells by artificial conductances. Biophys J. 1999;76:1423-1435.
35. Zhang M, Goforth P, Bertram R, Sherman A, Satin L. The Ca2+ dynamics of isolated mouse β-cells and islets: implications for mathematical models. Biophys J. 2003;84:2852-2870.
36. Bavamian S, Klee P, Britan A, et al. Islet-cell-to-cell communication as basis for normal insulin secretion. Diabetes Obes Metab. 2007;9(Suppl 2):118-132.
37. Martín F, Soria B. Glucose-induced [Ca2+]i oscillations in single human pancreatic islets. Cell Calcium. 1996;20:409-414.
38. Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci USA. 2006;103:2334-2339.
39. MacDonald MJ, Longacre MJ, Stoker SW, Kendrick M, Thonpho A, Brown LJ, Hasan NM, Jitrapakdee S, Fukao T, Hanson MS, Fernandez LA, Odorico J. Differences between human and rodent pancreatic islets low pyruvate carboxylase, ATP citrate lyase, and pyruvate carboxylation and high glucose-stimulated acetoacetate in human pancreatic islets. J Biol Chem. 2011;286:18383-18396.
40. Brissova M, Fowler MJ, Nicholson WE, et al. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem. 2005;53: 1087-1097.
41. Steiner DJ, Kim A, Miller K, Hara M. Pancreatic islet plasticity: interspecies comparison of islet architecture and composition. Islets. 2010;2:135-145.
42. Bosco D, Armanet M, Morel P, et al. Unique arrangement of α-and β-cells in human islets of Langerhans. Diabetes. 2010;59: 1202-1210.
43. Bonner-Weir S, Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes. 1982;31:883-889.
44. Samols E, Stagner JI, Ewart RB, Marks V. The order of islet microvascular cellular perfusion is B--A--D in the perfused rat pancreas. J Clin Invest. 1988;82:350-353.
45. Stagner JI, Samols E. The vascular order of islet cellular perfusion in the human pancreas. Diabetes. 1992;41:93-97.
46. Meda P, Amherdt M, Perrelet A, Orci L. Metabolic coupling between cultured pancreatic b-cells. Exp Cell Res. 1981;133:421-430.
47. Charpantier E, Cancela J, Meda P. β cells preferentially exchange cationic molecules via connexin 36 gap junction channels. Diabe tologia. 2007;50:2332-2341.
48. Ravier MA, Güldenagel M, Charollais A, et al. Loss of connexin36 channels alters β-cell coupling, islet synchronization of glucoseinduced Ca2+ and insulin oscillations, and basal insulin release. Diabetes. 2005;54:1798-1807.
49. Hauge-Evans AC, Squires PE, Persaud SJ, Jones PM. Pancreatic β-cell-to-β-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets. Diabetes. 1999;48:1402-1408.
50. Meda P, Perrelet A, Orci L. Increase of gap junctions between pancreatic B-cells during stimulation of insulin secretion. J Cell Biol. 1979;82:441-448.
51. Meda P, Michaels RL, Halban PA, Orci L, Sheridan JD. In vivo modulation of gap junctions and dye coupling between B-cells of the intact pancreatic islet. Diabetes. 1983;32:858-868.
52. Speier S, Gjinovci A, Charollais A, Meda P, Rupnik M. Cx36-mediated coupling reduces β-cell heterogeneity, confines the stimulating glucose concentration range, and affects insulin release kinetics. Diabetes. 2007;56:1078-1086.
53. Benninger RK, Head WS, Zhang M, Satin LS, Piston DW. Gap junctions and other mechanisms of cell-cell communication regulate basal insulin secretion in the pancreatic islet. J Physiol. 2011; 589:5453-5466.
54. Pfeffer F, Koczan D, Adam U, et al. Expression of connexin26 in islets of Langerhans is associated with impaired glucose tolerance in patients with pancreatic adenocarcinoma. Pancreas. 2004;29: 284-290.
55. Serre-Beinier V, Bosco D, Zulianello L, et al. Cx36 makes channels coupling human pancreatic β-cells, and correlates with insulin expression. Hum Mol Genet. 2009;18:428-439.
56. Hodson DJ, Mitchell RK, Bellomo EA, et al. Lipotoxicity disrupts incretin-regulated human β cell connectivity. J Clin Invest. 2013; 123:4182-4194.
57. Hodson DJ, Romanò N, Schaeffer M, et al. Coordination of calcium signals by pituitary endocrine cells in situ. Cell Calcium. 2012;51:222-230.
58. Mears D, Sheppard NF, Jr., Atwater I, Rojas E. Magnitude and modulation of pancreatic β-cell gap junction electrical conductance in situ. J Membr Biol. 1995;146:163-176.
59. Vera B, Sánchez-Abarca LI, Bolaños JP, Medina JM. Inhibition of astrocyte gap junctional communication by ATP depletion is reversed by calcium sequestration. FEBS Lett. 1996;392:225-228.
60. Caicedo A. Paracrine and autocrine interactions in the human islet: more than meets the eye. Semin Cell Dev Biol. 2013;24:11-21.
61. Rodriguez-Diaz R, Abdulreda MH, Formoso AL, et al. Innervation patterns of autonomic axons in the human endocrine pancreas. Cell Metab. 2011;14:45-54.
62. Deisseroth K. Optogenetics. Nat Methods. 2011;8:26-29.
63. Yang YH, Szabat M, Bragagnini C, et al. Paracrine signalling loops in adult human and mouse pancreatic islets: netrins modulate β cell apoptosis signalling via dependence receptors. Diabe tologia. 2011;54:828-842.
64. Rodriguez-Diaz R, Dando R, Jacques-Silva MC, et al. α Cells secrete acetylcholine as a non-neuronal paracrine signal priming β cell function in humans. Nat Med. 2011;17:888-892.
65. Kailey B, van de Bunt M, Cheley S, et al. SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β-and α-cells. Am J Physiol Endocrinol Metab. 2012;303:E1107-E1116.
66. Hauge-Evans AC, King AJ, Carmignac D, et al. Somatostatin secreted by islet β-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes. 2009;58:403-411.
67. Strowski MZ, Parmar RM, Blake AD, Schaeffer JM. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology. 2000;141:111-117.
68. Rutter GA. Regulating glucagon secretion: somatostatin in the spotlight. Diabetes. 2009;58:299-301.
69. Leibiger IB, Leibiger B, Moede T, Berggren PO. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/ PI-3 kinase/p70 s6 kinase andCaMkinase pathways. Mol Cell. 1998;1:933-938.
70. Kulkarni RN, Brüning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell. 1999;96:329-339.
71. Da Silva Xavier G, Qian Q, Cullen PJ, Rutter GA. Distinct roles for insulin and insulin-like growth factor-1 receptors in pancreatic β-cell glucose sensing revealed by RNA silencing. Biochem J. 2004;377:149-158.
72. Muller D, Huang GC, Amiel S, Jones PM, Persaud SJ. Identification of insulin signaling elements in human β-cells: autocrine regulation of insulin gene expression. Diabetes. 2006;55:2835-2842.
73. Bouche C, Lopez X, Fleischman A, et al. Insulin enhances glucosestimulated insulin secretion in healthy humans. Proc Natl Acad Sci USA. 2010;107:4770-4775.
74. Rhodes CJ, White MF, Leahy JL, Kahn SE. Direct autocrine action of insulin on β-cells: does it make physiological sense? Diabetes. 2013;62:2157-2163.
75. Tsuboi T, Rutter GA. Multiple forms of "kiss-and-run" exocytosis revealed by evanescent wave microscopy. Curr Biol. 2003;13: 563-567.
76. Rorsman P, Renström E. Insulin granule dynamics in pancreatic β cells. Diabetologia. 2003;46:1029-1045.
77. Cornu M, Yang JY, Jaccard E, Poussin C, Widmann C, Thorens B. Glucagon-like peptide-1 protects β-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop. Diabetes. 2009;58:1816-1825.
78. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341-1345.
79. Fernandez-Alvarez J, Hillaire-Buys D, Loubatières-Mariani MM, Gomis R, Petit P. P2 receptor agonists stimulate insulin release from human pancreatic islets. Pancreas. 2001;22:69-71.
80. Silva AM, Rodrigues RJ, Tomé AR, et al. Electrophysiological and immunocytochemical evidence for P2X purinergic receptors in pancreatic β cells. Pancreas. 2008;36:279-283.
81. Jacques-Silva MC, Correa-Medina M, Cabrera O, et al. ATPgated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic β cell. Proc Natl Acad Sci USA. 2010;107:6465-6470.
82. Shvartsman SY, Hagan MP, Yacoub A, Dent P, Wiley HS, Lauffenburger DA. Autocrine loops with positive feedback enable context-dependent cell signaling. Am J Physiol Cell Physiol. 2002; 282:C545-C559.
83. Braun M, Ramracheya R, Bengtsson M, et al. γ-Aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic β-cells. Diabetes. 2010;59:1694-1701.
84. Taneera J, Jin Z, Jin Y, et al. gamma-Aminobutyric acid (GABA) signalling in human pancreatic islets is altered in type 2 diabetes. Diabetologia. 2012;55:1985-1994.
85. Simpson N, Maffei A, Freeby M, et al. Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro. Mol Endocrinol. 2012;26:1757-1772.
86. Ustione A, Piston DW, Harris PE. Minireview: dopaminergic regulation of insulin secretion from the pancreatic islet. Mol Endocrinol. 2013;27:1198-1207.
87. Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 2001;22:724-763.
88. Freeby M, Ichise M, Harris PE. Vesicular monoamine transporter, type 2 (vmat2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas. Islets. 2012;4:393-397.
89. Batsilas L, Berezhkovskii AM, Shvartsman SY. Stochastic model of autocrine and paracrine signals in cell culture assays. Biophys J. 2003;85:3659-3665.
90. Moledina F, Clarke G, Oskooei A, Onishi K, Günther A, Zandstra PW. Predictive microfluidic control of regulatory ligand trajectories in individual pluripotent cells. Proc Natl Acad Sci USA. 2012; 109:3264-3269.
91. Ebert SN, Taylor DG. Catecholamines and development of cardiac pacemaking: an intrinsically intimate relationship. Cardiovasc Res. 2006;72:364-374.
92. Kashima Y, Miki T, Shibasaki T, et al. Critical role of cAMPGEFII-Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem. 2001;276:46046-46053.
93. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132:2131-2157.
94. Sonoda N, Imamura T, Yoshizaki T, Babendure JL, Lu JC, Olefsky JM. β-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic β cells. Proc Natl Acad Sci USA. 2008;105:6614-6619.
95. Quoyer J, Longuet C, Broca C, et al. GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a β-arrestin 1-mediated ERK1/2 activation in pancreatic β-cells. J Biol Chem. 2010; 285:1989-2002.
96. Seino Y, Fukushima M, Yabe D. GIP and GLP-1, the two incretin hormones: Similarities and differences. J Diabetes Invest. 2010;1: 8-23.
97. Leech CA, Dzhura I, Chepurny OG, et al. Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic β cells. Prog Biophys Mol Biol. 2011;107:236-247.
98. Pérez-Armendariz M, Roy C, Spray DC, Bennett MV. Biophysical properties of gap junctions between freshly dispersed pairs of mouse pancreatic β cells. Biophys J. 1991;59:76-92.
99. Rutter GA, Parton LE. The β-cell in type 2 diabetes and in obesity. Front Horm Res. 2008;36:118-134.
100. Prentki M, Nolan CJ. Islet β cell failure in type 2 diabetes. J Clin Invest. 2006;116:1802-1812.
101. Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat Med. 2006;12:75-80.
102. Kjems LL, Holst JJ, Vølund A, Madsbad S. The influence of GLP-1 on glucose-stimulated insulin secretion: effects on β-cell sensitivity in type 2 and nondiabetic subjects. Diabetes. 2003;52:380-386.
103. Knop FK, Aaboe K, Vilsboll T, Madsbad S, Krarup T, Holst JJ. Reduced incretin effect in obese subjects with normal glucose tolerance as compared to lean control subjects. Diabetologia. 2008; 51:S258-S258.
104. Højberg PV, Vilsbøll T, Rabøl R, et al. Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. Diabetologia. 2009;52: 199-207.
105. Holst JJ, Knop FK, Vilsboll T, Krarup T, Madsbad S. Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes. Diabetes Care 2011;34(Suppl. 2):S251-S257.
106. Knop FK, Aaboe K, Vilsboll T, et al. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity. Diabetes Obes Metab. 2012;14:500-510.
107. Marchetti P, Lupi R, Bugliani M, et al. A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia. 2012;55:3262-3272.
108. da Silva Xavier G, Loder MK, McDonald A, et al. TCF7L2 regulates late events in insulin secretion from pancreatic islet β-cells. Diabetes. 2009;58:894-905.
109. Nicolson TJ, Bellomo EA, Wijesekara N, et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes. 2009;58:2070-2083.
110. da Silva Xavier G, Mondragon A, Sun G, et al. Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice. Diabe tologia. 2012;55:2667-2676.
111. da Silva Xavier G, Bellomo EA, McGinty JA, French PM, Rutter GA. Animal models of GWAS-identified type 2 diabetes genes. J Diabetes Res. 2013;2013:906590.
112. Lurtz MM, Louis CF. Intracellular calcium regulation of connexin43. Am J Physiol Cell Physiol. 2007;293:C1806-C1813.
113. Sun Z, Zhang DQ, McMahon DG. Zinc modulation of hemi-gapjunction channel currents in retinal horizontal cells. J Neurophysiol. 2009;101:1774-1780.
114. Neuman RJ, Wasson J, Atzmon G, et al. Gene-gene interactions lead to higher risk for development of type 2 diabetes in an Ashkenazi Jewish population. PloS One. 2010;5:e9903.
115. Franks PW, Pearson E, Florez JC. Gene-environment and genetreatment interactions in type 2 diabetes: progress, pitfalls, and prospects. Diabetes Care. 2013;36:1413-1421.
116. Seino S, Shibasaki T, Minami K. Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J Clin Invest. 2011;121:2118-2125.
117. Wahren J, Kallas Å. Loss of pulsatile insulin secretion: a factor in the pathogenesis of type 2 diabetes? Diabetes. 2012;61:2228-2229.
118. Lafont C, Desarménien MG, Cassou M, et al. Cellular in vivo imaging reveals coordinated regulation of pituitary microcirculation and GH cell network function. Proc Natl Acad Sci USA. 2010;107:4465-4470.
119. Schaeffer M, Hodson DJ, Lafont C, Mollard P. Functional importance of blood flow dynamics and partial oxygen pressure in the anterior pituitary. Eur J Neurosci. 2010;32:2087-2095.
120. Schaeffer M, Hodson DJ, Lafont C, Mollard P. Endocrine cells and blood vessels work in tandem to generate hormone pulses. J Mol Endocrinol. 2011;47:R59-R66.
121. Nyman LR, Ford E, Powers AC, Piston DW. Glucose-dependent blood flow dynamics in murine pancreatic islets in vivo. Am J Physiol Endocrinol Metab. 2010;298:E807-E814.
122. Basu A, Dube S, Slama M, et al. Time lag of glucose from intravascular to interstitial compartment in humans [published online September 5, 2013]. Diabetes. doi:10.2337/db13-1132.
123. Rocheleau JV, Walker GM, Head WS, McGuinness OP, Piston DW. Microfluidic glucose stimulation reveals limited coordination of intracellular Ca2+ activity oscillations in pancreatic islets. Proc Natl Acad Sci USA. 2004;101:12899-12903.
124. Svensson AM, Ostenson CG, Jansson L. Age-induced changes in pancreatic islet blood flow: evidence for an impaired regulation in diabetic GK rats. Am J Physiol Endocrinol Metab. 2000;279: E1139-E1144.
125. Li X, Zhang L, Meshinchi S, et al. Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes. Diabetes. 2006;55:2965-2973.
126. Pørksen N, Munn S, Steers J, Veldhuis JD, Butler PC. Effects of glucose ingestion versus infusion on pulsatile insulin secretion. The incretin effect is achieved by amplification of insulin secretory burst mass. Diabetes. 1996;45:1317-1323.